0.0028
0.0000
(0.00%)
At close: April 17 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Frederick Dominick Sancilio M.S., Ph.D. | Chairman & CEO | -- | -- | 1950 |
| Mr. Charles F. Goulburn | President & Director | -- | -- | -- |
| Mr. Mathew Lee C.A., CPA | Chief Financial Officer | 57.57k | -- | 1985 |
| Mr. Maghsoud Dariani | Chief Science Officer | -- | -- | 1955 |
| Dr. Herman Williams M.D. | CEO Alt, Inc | -- | -- | 1960 |
Lobe Sciences Ltd.
1771 Robson Street
Suite 1614
Vancouver, BC V6G 3B7
Canada
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. was founded in 2018 and is headquartered in Vancouver, Canada.
Corporate Governance
Lobe Sciences Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
April 28, 2025 at 8:00 PM UTC - May 2, 2025 at 8:00 PM UTC
Lobe Sciences Ltd. Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
BRAXF Braxia Scientific Corp.
0.0010
+11.11%
BIOV.CN BioVaxys Technology Corp.
0.0500
0.00%
GOVXW GeoVax Labs, Inc.
0.0331
0.00%
BVAXF BioVaxys Technology Corp.
0.0388
0.00%
PHRRF PharmaTher Holdings Ltd.
0.1500
0.00%
GNLX Genelux Corporation
2.6300
+2.33%
MBIO Mustang Bio, Inc.
1.3300
-0.75%
GALT Galectin Therapeutics Inc.
1.3800
+0.73%
ATAI Atai Life Sciences N.V.
1.4700
+3.52%
CYBN Cybin Inc.
7.35
-1.34%